Picture of Biofrontera AG logo

B8F Biofrontera AG Cashflow Statement

0.000.00%
de flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for Biofrontera AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-16.1-19.3-4.78-12.735.7
Depreciation
Non-Cash Items2.173-13.86.3-12.6
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.0752.08-17.5-1.784.05
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Cash from Operating Activities-13.1-13.4-32.9-2.8530.4
Capital Expenditures-0.397-0.513-1.85-0.774-0.629
Purchase of Fixed Assets
Other Investing Cash Flow Items0.0220.00222.93.65-41.6
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities-0.375-0.51121.12.87-42.3
Financing Cash Flow Items-1.26-2.3-0.667-1.19-6.86
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities9.4522.33.465.952.18
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-4.048.37-8.335.43-9.64

Or unlock with your email

Or unlock with your email